Learn More
Apexbio Technology LLC TG101209 936091-14-4 200mg

Supplier: Apexbio Technology LLC A4145200
TG101209 (CAS 936091-14-4) is a structurally designed small molecule that functions as a selective inhibitor of Janus kinase 2 (JAK2) It inhibits the JAK/STAT signaling pathway particularly in cell lines harboring JAK2V617F or MPLW515L/K mutations commonly associated with polycythemia vera and primary myelofibrosis respectively In studies using multiple myeloma cell models TG101209 reduces the expression of phosphorylated JAK2 STAT3 and Bcl-xL while inducing overexpression of phosphorylated Erk and Akt This modulation of signaling pathways results in dose- and time-dependent cytotoxicity linked to cell cycle arrest and apoptosis supporting its utility in research on hematological malignancies driven by JAK2 dysregulation
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.